{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:02:28Z","timestamp":1778695348901,"version":"3.51.4"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/shk.0b013e31819940cb","type":"journal-article","created":{"date-parts":[[2009,8,11]],"date-time":"2009-08-11T08:14:06Z","timestamp":1249978446000},"page":"263-269","source":"Crossref","is-referenced-by-count":59,"title":["EVODIAMINE REPRESSES HYPOXIA-INDUCED INFLAMMATORY PROTEINS EXPRESSION AND HYPOXIA-INDUCIBLE FACTOR 1\u03b1 ACCUMULATION IN RAW264.7"],"prefix":"10.1097","volume":"32","author":[{"given":"Yi-Nan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiow-Lin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cho-Hwa","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Der-Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jih-Hwa","family":"Guh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chieh-Yu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Ling","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Che-Ming","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210213","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis-an inflammatory disease.","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"R2-6-20210213","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/01.ATV.19.4.870","article-title":"Evidence of hypoxic areas within the arterial wall in vivo.","volume":"19","author":"Bjornheden","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R3-6-20210213","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1182\/blood-2004-03-1109","article-title":"Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues.","volume":"104","author":"Murdoch","year":"2004","journal-title":"Blood"},{"key":"R4-6-20210213","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.4049\/jimmunol.175.10.6257","article-title":"Hypoxia regulates macrophage functions in inflammation.","volume":"175","author":"Murdoch","year":"2005","journal-title":"J Immunol"},{"key":"R5-6-20210213","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0002-9440(10)63483-9","article-title":"Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy.","volume":"163","author":"Burke","year":"2003","journal-title":"Am J Pathol"},{"key":"R6-6-20210213","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/jlb.66.6.889","article-title":"Macrophage responses to hypoxia: relevance to disease mechanisms.","volume":"66","author":"Lewis","year":"1999","journal-title":"J Leukoc Biol"},{"key":"R7-6-20210213","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0092-8674(03)00154-5","article-title":"HIF-1alpha is essential for myeloid cell-mediated inflammation.","volume":"112","author":"Cramer","year":"2003","journal-title":"Cell"},{"key":"R8-6-20210213","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"R9-6-20210213","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1091\/mbc.e07-04-0391","article-title":"Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells.","volume":"18","author":"Belaiba","year":"2007","journal-title":"Mol Biol Cell"},{"key":"R10-6-20210213","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1182\/blood-2003-07-2427","article-title":"Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1alpha.","volume":"103","author":"Blouin","year":"2004","journal-title":"Blood"},{"key":"R11-6-20210213","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1471-4914(01)02090-1","article-title":"Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology.","volume":"7","author":"Semenza","year":"2001","journal-title":"Trends Mol Med"},{"key":"R12-6-20210213","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy.","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"R13-6-20210213","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1046\/j.1432-1033.2003.03446.x","article-title":"The subtle side to hypoxia inducible factor (HIFalpha) regulation.","volume":"270","author":"Bilton","year":"2003","journal-title":"Eur J Biochem"},{"key":"R14-6-20210213","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1357-2725(98)00130-7","article-title":"Protein synthesis initiation factor 4G.","volume":"31","author":"Keiper","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"key":"R15-6-20210213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/dbio.1998.9131","article-title":"Translational recruitment of Xenopus maternal mRNAs in response to poly(A) elongation requires initiation factor eIF4G-1.","volume":"206","author":"Keiper","year":"1999","journal-title":"Dev Biol"},{"key":"R16-6-20210213","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1128\/MCB.19.6.4302","article-title":"Translational homeostasis: eukaryotic translation initiation factor 4E control of 4E-binding protein 1 and p70 S6 kinase activities.","volume":"19","author":"Khaleghpour","year":"1999","journal-title":"Mol Cell Biol"},{"key":"R17-6-20210213","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0014-5793(97)00323-2","article-title":"The modular phosphorylation and activation of p70s6k.","volume":"410","author":"Pullen","year":"1997","journal-title":"FEBS Lett"},{"key":"R18-6-20210213","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1101\/gad.13.11.1422","article-title":"Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism.","volume":"13","author":"Gingras","year":"1999","journal-title":"Genes Dev"},{"key":"R19-6-20210213","doi-asserted-by":"crossref","first-page":"27975","DOI":"10.1074\/jbc.M204152200","article-title":"Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase\/target of rapamycin-dependent signaling pathway.","volume":"277","author":"Treins","year":"2002","journal-title":"J Biol Chem"},{"key":"R20-6-20210213","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejphar.2006.10.002","article-title":"Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioactive components on neutrophils and microglial cells.","volume":"555","author":"Ko","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"R21-6-20210213","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1021\/np960495z","article-title":"Inhibitory effect of dehydroevodiamine and evodiamine on nitric oxide production in cultured murine macrophages.","volume":"60","author":"Chiou","year":"1997","journal-title":"J Nat Prod"},{"key":"R22-6-20210213","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1248\/bpb.24.917","article-title":"Inhibitory effects of evodiamine on in vitro invasion and experimental lung metastasis of murine colon cancer cells.","volume":"24","author":"Ogasawara","year":"2001","journal-title":"Biol Pharm Bull"},{"issue":"Suppl 5","key":"R23-6-20210213","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1634\/theoncologist.9-90005-10","article-title":"The role of hypoxia-induced factors in tumor progression.","volume":"9","author":"Vaupel","year":"2004","journal-title":"Oncologist"},{"key":"R24-6-20210213","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1084\/jem.182.6.1683","article-title":"A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter.","volume":"182","author":"Melillo","year":"1995","journal-title":"J Exp Med"},{"key":"R25-6-20210213","doi-asserted-by":"crossref","first-page":"17203","DOI":"10.1074\/jbc.M500077200","article-title":"Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion.","volume":"280","author":"Takada","year":"2005","journal-title":"J Biol Chem"},{"key":"R26-6-20210213","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1038\/sj.onc.1210169","article-title":"YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt\/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.","volume":"26","author":"Sun","year":"2007","journal-title":"Oncogene"},{"key":"R27-6-20210213","doi-asserted-by":"crossref","first-page":"13506","DOI":"10.1074\/jbc.M310164200","article-title":"PI3K\/Akt is required for heat shock proteins to protect hypoxia-inducible factor 1alpha from pVHL-independent degradation.","volume":"279","author":"Zhou","year":"2004","journal-title":"J Biol Chem"},{"key":"R28-6-20210213","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1091\/mbc.e02-09-0598","article-title":"Tumor necrosis factor-alpha causes accumulation of a ubiquitinated form of hypoxia inducible factor-1alpha through a nuclear factor-kappaB-dependent pathway.","volume":"14","author":"Zhou","year":"2003","journal-title":"Mol Biol Cell"},{"key":"R29-6-20210213","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1124\/mol.106.027029","article-title":"Hypoxia-inducible factor-1 (HIF-1).","volume":"70","author":"Ke","year":"2006","journal-title":"Mol Pharmacol"},{"key":"R30-6-20210213","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1124\/mol.59.5.1216","article-title":"Mitogen-activated protein kinase kinase inhibitor PD98059 blocks the trans-activation but not the stabilization or DNA binding ability of hypoxia-inducible factor-1alpha.","volume":"59","author":"Hur","year":"2001","journal-title":"Mol Pharmacol"},{"key":"R31-6-20210213","doi-asserted-by":"crossref","first-page":"32631","DOI":"10.1074\/jbc.274.46.32631","article-title":"p42\/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1.","volume":"274","author":"Richard","year":"1999","journal-title":"J Biol Chem"},{"key":"R32-6-20210213","doi-asserted-by":"crossref","first-page":"33709","DOI":"10.1074\/jbc.274.47.33709","article-title":"EPAS1 trans-activation during hypoxia requires p42\/p44 MAPK.","volume":"274","author":"Conrad","year":"1999","journal-title":"J Biol Chem"},{"key":"R33-6-20210213","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1124\/mol.54.5.749","article-title":"Mersalyl is a novel inducer of vascular endothelial growth factor gene expression and hypoxia-inducible factor 1 activity.","volume":"54","author":"Agani","year":"1998","journal-title":"Mol Pharmacol"},{"key":"R34-6-20210213","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.leukres.2006.08.001","article-title":"Longitudinal inhibition of PI3K\/Akt\/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells.","volume":"31","author":"Ikezoe","year":"2007","journal-title":"Leuk Res"},{"key":"R35-6-20210213","doi-asserted-by":"crossref","first-page":"38205","DOI":"10.1074\/jbc.M203781200","article-title":"Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells.","volume":"277","author":"Fukuda","year":"2002","journal-title":"J Biol Chem"},{"key":"R36-6-20210213","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.1212704","article-title":"Upstream and downstream of mTOR.","volume":"18","author":"Hay","year":"2004","journal-title":"Genes Dev"},{"key":"R37-6-20210213","first-page":"1541","article-title":"Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor\/phosphatidylinositol 3-kinase\/PTEN\/AKT\/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.","volume":"60","author":"Zhong","year":"2000","journal-title":"Cancer Res"}],"container-title":["Shock"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SHK.0b013e31819940cb","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:22:48Z","timestamp":1620973368000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00024382-200909000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/shk.0b013e31819940cb","relation":{},"ISSN":["1073-2322"],"issn-type":[{"value":"1073-2322","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}